Nine Chapters Capital Management’s Protalix BioTherapeutics PLX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-2,130	Closed	-$9K	–	286
2016 Q4	$9K	Buy	+2,130	New	+$9K	0.02%	171
2015 Q3	–	Sell	-3,510	Closed	-$68K	–	1136
2015 Q2	$68K	Buy	3,510 +1,980	+129%	+$38.4K	0.01%	897
2015 Q1	$27K	Buy	+1,530	New	+$27K	﹤0.01%	937